{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:46:45Z","timestamp":1761130005442,"version":"3.41.2"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T00:00:00Z","timestamp":1658966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"Background<\/jats:title>The clinical spectrum of COVID-19 is broad, from asymptomatic to severe cases and death. The objective of this study is to analyze the clinical course of patients attended during the first months of the SARS-CoV-2 pandemic in a third-level pediatric hospital.<\/jats:p><\/jats:sec>Methods<\/jats:title>Design:<\/jats:italic> prospective cohort study. Patients with viral respiratory disease or suspected cases of COVID-19 were evaluated at the Pediatric Hospital, National Medical Center XXI Century, Mexico City, from 21 March 2020 to 13 January 2021. Statistical analysis:<\/jats:italic> Chi-square test and Fisher\u2019s exact test were used for comparisons; a logistic regression model was constructed to identify clinical or laboratory characteristics associated with critical disease. A p<\/jats:italic>-value &lt; 0.05 was considered statistically significant.<\/jats:p><\/jats:sec>Results<\/jats:title>A total of 697 patients met the operational definition of viral respiratory disease or suspected cases of COVID-19 and underwent real-time reverse transcription polymerase chain reaction (rRT-PCR) SARS-CoV-2 testing. Patients with a positive result were included. Of the 181 patients (26%), 121 (66.8%) had mild disease and were treated as outpatients and 60 (33.1%) were hospitalized. A total of six patients met the criteria for multisystem inflammatory syndrome in children (MIS-C). Of the 60 inpatients, 65% were males, and 82% had one or more comorbidities. The main comorbidities were cancer (42%) and overweight (15%). The median hospital stay was 9 days. The inpatients had a higher frequency of fever, general malaise, dyspnea, chills, polypnea, and cyanosis than the outpatients (p<\/jats:italic> &lt; 0.05). Only 21.4% of the outpatients had one or more comorbidities, which were lower than in the hospitalized patients (p<\/jats:italic> &lt; 0.001). Laboratory data at admission were similar between critically ill and those with moderate and severe disease. The patients who developed pneumonia were at higher risk of critical disease, while older age was associated with a better prognosis. A total of 13 of the 60 inpatients died (mortality 7.1%). All but one had one or more comorbidities: four had cancer, four congenital heart disease, one chronic kidney disease and epilepsy, one Epstein\u2013Barr virus-induced hemophagocytic lymphohistiocytosis, one obesity, and one diabetes mellitus.<\/jats:p><\/jats:sec>Conclusion<\/jats:title>Hospital mortality is high, especially in children with comorbidities. Despite 2 years having passed since the beginning of the COVID-19 pandemic, the epidemiological and clinical data on children are still helpful to improve their prognosis.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fped.2022.912784","type":"journal-article","created":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T05:48:05Z","timestamp":1658987285000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Clinical presentation of pediatric patients with symptomatic SARS-CoV-2 infection during the first months of the COVID-19 pandemic in a single center in Mexico City"],"prefix":"10.3389","volume":"10","author":[{"given":"Ranferi","family":"Arag\u00f3n-Nogales","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessie","family":"Zurita-Cruz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillermo","family":"V\u00e1zquez-Rosales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Arias-Flores","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"G\u00f3mez-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria","family":"Monta\u00f1o-Luna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariana","family":"S\u00e1mano-Avi\u00f1a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Pacheco-Rosas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Flores-Ruiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"Villas\u00eds-Keever","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guadalupe","family":"Miranda-Novales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,7,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2020.591132","article-title":"Epidemiological and clinical characteristics of COVID-19 in children: a systematic review and meta-analysis.","volume":"8","author":"Li","year":"2020","journal-title":"Front Pediatr."},{"journal-title":"Direcci\u00f3n General de Epidemiolog\u00eda. Secretar\u00eda de Salud. Datos Abiertos COVID-19.","year":"2022","key":"B2"},{"journal-title":"Lineamiento Estandarizado de la Vigilancia Epidemiol\u00f3gica y por Laboratorio de la Enfermedad Respiratoria Viral.","year":"2021","key":"B3"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph18083919","article-title":"COVID-19 management in the pediatric age: consensus document of the COVID-19 working group in paediatrics of the Emilia-Romagna region (RE-CO-Ped), Italy.","volume":"18","author":"Esposito","year":"2021","journal-title":"Int J Environ Res Public Health."},{"journal-title":"Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with Coronavirus Disease 2019 (COVID-19).","year":"2022","key":"B5"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1542\/peds.2020-0702","article-title":"Epidemiology of COVID-19 among children in China.","volume":"145","author":"Dong","year":"2020","journal-title":"Pediatrics."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1001\/jama.2020.2648","article-title":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention.","volume":"323","author":"Wu","year":"2020","journal-title":"JAMA."},{"key":"B8","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1001\/jamapediatrics.2020.5052","article-title":"Assessment of 135,794 pediatric patients tested for Severe Acute Respiratory Syndrome Coronavirus 2 across the United States.","volume":"175","author":"Bailey","year":"2021","journal-title":"JAMA Pediatr."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1186\/s12887-020-02316-1","article-title":"Children with COVID-19 behaving milder may challenge the public policies: a systematic review and meta-analysis.","volume":"20","author":"Liu","year":"2020","journal-title":"BMC Pediatr."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjoto.2020.102573","article-title":"Pediatric COVID-19: systematic review of the literature.","volume":"41","author":"Patel","year":"2020","journal-title":"Am J Otolaryngol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1002\/jmv.26208","article-title":"The clinical characteristics of pediatric inpatients with SARS-CoV-2 infection: a meta-analysis and systematic review.","volume":"93","author":"Ma","year":"2021","journal-title":"J Med Virol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"e364","DOI":"10.1097\/INF.0000000000003240","article-title":"Acute abdomen and appendicitis in 1010 pediatric patients with COVID-19 or MIS-C: a multinational experience from Latin America.","volume":"40","author":"Yock-Corrales","year":"2021","journal-title":"Pediatr Infect Dis J."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-89553-1","article-title":"A retrospective cohort study of 12,306 pediatric COVID-19 patients in the United States.","volume":"11","author":"Parcha","year":"2021","journal-title":"Sci Rep."},{"key":"B14","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1001\/jamapediatrics.2020.4573","article-title":"Susceptibility to SARS-CoV-2 infection among children and adolescents compared with adults. A systematic review and meta-analysis.","volume":"175","author":"Viner","year":"2021","journal-title":"JAMA Pediatr."},{"key":"B15","first-page":"86","article-title":"Impact of COVID-19 pandemic on chronic diseases care follow-up and current perspectives in low resource settings: a narrative review.","volume":"13","author":"Fekadu","year":"2021","journal-title":"Int J Physiol Pathophysiol Pharmacol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.jinf.2021.11.011","article-title":"Persistent symptoms following SARS-CoV-2 infection amongst children and young people: a meta-analysis of controlled and uncontrolled studies.","volume":"84","author":"Behnood","year":"2022","journal-title":"J Infect."},{"key":"B17","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/s41590-021-01123-9","article-title":"Immunology of SARS-CoV-2 infection in children.","volume":"23","author":"Chou","year":"2022","journal-title":"Nat Immunol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1007\/s13312-021-2126-5","article-title":"Clinical spectrum of COVID-19 in a mexican pediatric population.","volume":"58","author":"Bustos-Cordova","year":"2021","journal-title":"Indian Pediatr."},{"key":"B19","doi-asserted-by":"publisher","first-page":"18","DOI":"10.24875\/BMHIM.200002021","article-title":"Clinical and epidemiological characteristics of children with SARS-CoV-2 infection: a case series in Sinaloa.","volume":"78","author":"P\u00e9rez-Gaxiola","year":"2021","journal-title":"Bol Med Hosp Infant Mex."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2022.868297","article-title":"Factors associated with hospitalization or intensive care admission in children with COVID-19 in Latin America.","volume":"10","author":"L\u00f3pez-Medina","year":"2022","journal-title":"Front Pediatr."},{"key":"B21","doi-asserted-by":"publisher","first-page":"442","DOI":"10.2471\/BLT.20.268573","article-title":"Tackling antimicrobial resistance in the COVID-19 pandemic.","volume":"98","author":"Getahun","year":"2020","journal-title":"Bull World Health Organ."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1089\/mdr.2020.0619","article-title":"The spectrum of antibiotic prescribing during COVID-19 pandemic: a systematic literature review.","volume":"27","author":"Al-Hadidi","year":"2021","journal-title":"Microb Drug Resist."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1111\/apa.15847","article-title":"High rates of antibiotic prescriptions in children with COVID-19 or multisystem inflammatory syndrome: a multinational experience in 990 cases from Latin America.","volume":"110","author":"Yock-Corrales","year":"2021","journal-title":"Acta Paediatr."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2021.738423","article-title":"COVID-19 incidence and mortality by age strata and comorbidities in Mexico City: a focus in the pediatric population.","volume":"9","author":"Gonz\u00e1lez-Garc\u00eda","year":"2021","journal-title":"Front Public Health."},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1093\/tropej\/fmab025","article-title":"Clinical and epidemiological characteristics of paediatric patients diagnosed with COVID-19 in a tertiary hospital in Mexico City.","volume":"67","author":"Macias-Parra","year":"2021","journal-title":"J Trop Pediatr."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.15585\/mmwr.mm7036e2","article-title":"Hospitalizations associated with COVID-19 among children and adolescents \u2014 COVID-NET, 14 States, March 1, 2020\u2013August 14, 2021.","volume":"70","author":"Delahoy","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1101\/2021.08.20.21262122","article-title":"Pediatric critical COVID-19 and mortality in a multinational cohort.","author":"Gonzalez-Dambrauskas","year":"2021","journal-title":"medRxiv"},{"key":"B28","doi-asserted-by":"publisher","first-page":"80","DOI":"10.5546\/aap.2022.eng.80","article-title":"A multicenter study of confirmed COVID-19 cases: preliminary data of 2690 pediatric patients in Argentina during the first year of the pandemic.","volume":"120","author":"Gentile","year":"2022","journal-title":"Arch Argent Pediatr."},{"key":"B29","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/S2352-4642(21)00134-6","article-title":"Clinical characteristics and risk factors for death among hospitalised children and adolescents with COVID-19 in Brazil: an analysis of a nationwide database.","volume":"5","author":"Oliveira","year":"2021","journal-title":"Lancet Child Adolesc Health."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2022.881765","article-title":"Multisystem inflammatory syndrome temporally related to COVID-19 in children from Latin America and the Caribbean region: a systematic review with a meta-analysis of data from regional surveillance systems.","volume":"10","author":"Ruvinsky","year":"2022","journal-title":"Front Pediatr."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101287","article-title":"Which children and young people are at higher risk of severe disease and death after hospitalisation with SARS-CoV-2 infection in children and young people: a systematic review and individual patient meta-analysis.","volume":"44","author":"Harwood","year":"2022","journal-title":"EClinicalMedicine."}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2022.912784\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T05:48:10Z","timestamp":1658987290000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2022.912784\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,28]]},"references-count":31,"alternative-id":["10.3389\/fped.2022.912784"],"URL":"https:\/\/doi.org\/10.3389\/fped.2022.912784","relation":{},"ISSN":["2296-2360"],"issn-type":[{"type":"electronic","value":"2296-2360"}],"subject":[],"published":{"date-parts":[[2022,7,28]]},"article-number":"912784"}}